| Product Code: ETC6735747 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Adeno Associated Virus Vector Manufacturing Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 China Adeno Associated Virus Vector Manufacturing Market - Industry Life Cycle |
3.4 China Adeno Associated Virus Vector Manufacturing Market - Porter's Five Forces |
3.5 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Scale of Operations, 2021 & 2031F |
3.6 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Therapeutic Area Scope, 2021 & 2031F |
3.7 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume Share, By Method Scope, 2021 & 2031F |
4 China Adeno Associated Virus Vector Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for gene therapy treatments in China |
4.2.2 Technological advancements in vector manufacturing processes |
4.2.3 Growing investments in pharmaceutical and biotech industries in China |
4.3 Market Restraints |
4.3.1 Regulatory hurdles and complexities in gene therapy approvals in China |
4.3.2 High costs associated with AAV vector manufacturing |
4.3.3 Limited expertise and skilled workforce in AAV vector manufacturing industry |
5 China Adeno Associated Virus Vector Manufacturing Market Trends |
6 China Adeno Associated Virus Vector Manufacturing Market, By Types |
6.1 China Adeno Associated Virus Vector Manufacturing Market, By Scale of Operations |
6.1.1 Overview and Analysis |
6.1.2 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Scale of Operations, 2021- 2031F |
6.1.3 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.4 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Preclinical, 2021- 2031F |
6.1.5 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Commercial, 2021- 2031F |
6.2 China Adeno Associated Virus Vector Manufacturing Market, By Therapeutic Area Scope |
6.2.1 Overview and Analysis |
6.2.2 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Hematological Diseases, 2021- 2031F |
6.2.3 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021- 2031F |
6.2.5 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Ophthalmic Disorders, 2021- 2031F |
6.3 China Adeno Associated Virus Vector Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.3 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.4 China Adeno Associated Virus Vector Manufacturing Market, By Method Scope |
6.4.1 Overview and Analysis |
6.4.2 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By In Vitro, 2021- 2031F |
6.4.3 China Adeno Associated Virus Vector Manufacturing Market Revenues & Volume, By In Vivo, 2021- 2031F |
7 China Adeno Associated Virus Vector Manufacturing Market Import-Export Trade Statistics |
7.1 China Adeno Associated Virus Vector Manufacturing Market Export to Major Countries |
7.2 China Adeno Associated Virus Vector Manufacturing Market Imports from Major Countries |
8 China Adeno Associated Virus Vector Manufacturing Market Key Performance Indicators |
8.1 Research and development spending in gene therapy sector |
8.2 Number of gene therapy clinical trials using AAV vectors in China |
8.3 Adoption rate of AAV vectors in gene therapy treatments in China |
8.4 Investment in infrastructure for AAV vector manufacturing |
8.5 Number of partnerships and collaborations in AAV vector manufacturing sector |
9 China Adeno Associated Virus Vector Manufacturing Market - Opportunity Assessment |
9.1 China Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Scale of Operations, 2021 & 2031F |
9.2 China Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Therapeutic Area Scope, 2021 & 2031F |
9.3 China Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 China Adeno Associated Virus Vector Manufacturing Market Opportunity Assessment, By Method Scope, 2021 & 2031F |
10 China Adeno Associated Virus Vector Manufacturing Market - Competitive Landscape |
10.1 China Adeno Associated Virus Vector Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 China Adeno Associated Virus Vector Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here